Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-336-5 | CAS number: 94-47-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 2002 - October 2003
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Data is from study report.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not specified
- Principles of method if other than guideline:
- The purpose of this study was to assess the Toxicological profile of test item to a single administration via oral route to rats.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Phenethyl benzoate
- EC Number:
- 202-336-5
- EC Name:
- Phenethyl benzoate
- Cas Number:
- 94-47-3
- Molecular formula:
- C15H14O2
- IUPAC Name:
- 2-phenylethyl benzoate
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: healthy rats
- Weight at study initiation: The pretest body weight range was 316- 350 grams for males and 243- 276 grams for females. The weight variation of the animals used did not exceed +/- 20% of the mean weight.
- Fasting period before study: 16-20 hours
- Housing/Identification/Bedding: The animals were identified by cage notation and indelible body marks, and housed 5/sex/cage in suspended wire cages. Bedding was placed beneath the cages and changed at least three times/week.
- Diet (e.g. ad libitum): Fresh PMI Rat Chow was freely available except for 16-20 hours prior to dosing.
- Water (e.g. ad libitum): Water was freely available at all times.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): temperature controlled
- Air changes (per hr): was kept clean and vermin free.
- Photoperiod (hrs dark / hrs light): a 12 hour light/dark cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- not specified
- Doses:
- 2000 mg/kg b.w.
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed 1, 2 and 4 hours postdose and once daily for 14 days for toxicity effects. The animals were observed twice daily for mortality. Body weights were recorded immediately pretest, weekly and at termination.
- Necropsy of survivors performed: yes, All animals were humanely sacrificed using CO2 and examined for gross pathology. Abnormal tissues were preserved in 10% buffered formalin for possible future microscopic examination. - Statistics:
- An estimate of the LD50 was made based on the results.
Results and discussion
- Preliminary study:
- not specified
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed at 2000 mg/kg bw.
- Clinical signs:
- other: Instances of lethargy, wet anogenital area, ataxia, soiled anogenital area and diarrhea were noted on the day of dosing. All animals appeared normal from day 1 to day 14.
- Gross pathology:
- Necropsy results were normal in 9/10 animals. One animal had mottled kidneys.
- Other findings:
- None
Applicant's summary and conclusion
- Interpretation of results:
- other: Not classified
- Conclusions:
- The lethal concentration (LD50) value for acute oral toxicity test was considered to be >2000 mg/kgbw, when male and female wistar rats were treated with test chemical orally via gavage according to OECD Guideline 401 (Acute Oral Toxicity).
- Executive summary:
The acute oral toxicity profile of the given test chemical was conducted according to OECD Guideline 401 (Acute Oral Toxicity) in Wistar rats.
10 Healthy male and female wistar rats were used for the study. The given test chemical was administered via oral gavage route with the dose concentration of 2000 mg/kg b.w.
Animals were observed 1, 2 and 4 hours postdose and once daily for 14 days for toxicity effects. The animals were observed twice daily for mortality. Body weights were recorded immediately pretest, weekly and at termination. All animals were humanely sacrificed using CO2 and examined for gross pathology. Abnormal tissues were preserved in 10% buffered formalin for possible future microscopic examination. An estimate of the LD50 was made based on the results.
No mortality was observed at 2000 mg/kg bw. Instances of lethargy, wet anogenital area, ataxia, soiled anogenital area and diarrhea were noted on the day of dosing. All animals appeared normal from day 1 to day 14. Body weight changes were normal. Necropsy results were normal in 9/10 animals. One animal had mottled kidneys.
Under the condition of the study, the lethal concentration (LD50) value for acute oral toxicity test was considered to be >2000 mg/kgbw, when male and female wistar rats were treated with test chemical orally via gavage according to OECD Guideline 401 (Acute Oral Toxicity).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.